<?xml version="1.0" encoding="UTF-8"?>
<p>(
 <bold>a</bold>) SciIAVs with deletion or substitution of a viral component: The most common strategy to generate a sciIAV is the complete or partial deletion of a viral component. However, it has been shown that the presence of eight viral segments and the vRNA packaging network may be important for optimal virus fitness [
 <xref rid="B195-viruses-11-00190" ref-type="bibr">195</xref>]. To reconstitute the full viral genome, the modified viral gene should contain the packaging signals and NCRs of the native segment, allowing for the insertion of foreign genes (e.g., reporter genes encoding fluorescent or luciferase proteins) [
 <xref rid="B190-viruses-11-00190" ref-type="bibr">190</xref>]. Different sciIAVs have been generated for a diverse range of purposes by deleting PB2 (ΔPB2, 
 <xref ref-type="fig" rid="viruses-11-00190-f009">Figure 9</xref>A) [
 <xref rid="B194-viruses-11-00190" ref-type="bibr">194</xref>,
 <xref rid="B196-viruses-11-00190" ref-type="bibr">196</xref>,
 <xref rid="B201-viruses-11-00190" ref-type="bibr">201</xref>,
 <xref rid="B202-viruses-11-00190" ref-type="bibr">202</xref>,
 <xref rid="B203-viruses-11-00190" ref-type="bibr">203</xref>,
 <xref rid="B204-viruses-11-00190" ref-type="bibr">204</xref>], PB1 (ΔPB1, 
 <xref ref-type="fig" rid="viruses-11-00190-f009">Figure 9</xref>B) [
 <xref rid="B198-viruses-11-00190" ref-type="bibr">198</xref>,
 <xref rid="B199-viruses-11-00190" ref-type="bibr">199</xref>,
 <xref rid="B200-viruses-11-00190" ref-type="bibr">200</xref>], HA (ΔHA, 
 <xref ref-type="fig" rid="viruses-11-00190-f009">Figure 9</xref>C) [
 <xref rid="B102-viruses-11-00190" ref-type="bibr">102</xref>,
 <xref rid="B106-viruses-11-00190" ref-type="bibr">106</xref>,
 <xref rid="B195-viruses-11-00190" ref-type="bibr">195</xref>,
 <xref rid="B205-viruses-11-00190" ref-type="bibr">205</xref>,
 <xref rid="B206-viruses-11-00190" ref-type="bibr">206</xref>,
 <xref rid="B207-viruses-11-00190" ref-type="bibr">207</xref>,
 <xref rid="B209-viruses-11-00190" ref-type="bibr">209</xref>], or NA (ΔNA, 
 <xref ref-type="fig" rid="viruses-11-00190-f009">Figure 9</xref>D) [
 <xref rid="B194-viruses-11-00190" ref-type="bibr">194</xref>,
 <xref rid="B210-viruses-11-00190" ref-type="bibr">210</xref>,
 <xref rid="B211-viruses-11-00190" ref-type="bibr">211</xref>,
 <xref rid="B212-viruses-11-00190" ref-type="bibr">212</xref>,
 <xref rid="B215-viruses-11-00190" ref-type="bibr">215</xref>] viral genes and providing the missing protein 
 <italic>in trans</italic> by generating PB2- (
 <xref ref-type="fig" rid="viruses-11-00190-f009">Figure 9</xref>A), PB1- (
 <xref ref-type="fig" rid="viruses-11-00190-f009">Figure 9</xref>B), or HA- (
 <xref ref-type="fig" rid="viruses-11-00190-f009">Figure 9</xref>C) expressing stable cells lines, or by addition of exogenous NA in the tissue culture supernatant for the efficient release of infectious viral particles in the case of ΔNA (
 <xref ref-type="fig" rid="viruses-11-00190-f009">Figure 9</xref>D). However, only PB2- [
 <xref rid="B201-viruses-11-00190" ref-type="bibr">201</xref>,
 <xref rid="B202-viruses-11-00190" ref-type="bibr">202</xref>,
 <xref rid="B203-viruses-11-00190" ref-type="bibr">203</xref>,
 <xref rid="B204-viruses-11-00190" ref-type="bibr">204</xref>], HA- [
 <xref rid="B205-viruses-11-00190" ref-type="bibr">205</xref>,
 <xref rid="B206-viruses-11-00190" ref-type="bibr">206</xref>,
 <xref rid="B209-viruses-11-00190" ref-type="bibr">209</xref>], and NA-deficient [
 <xref rid="B210-viruses-11-00190" ref-type="bibr">210</xref>,
 <xref rid="B211-viruses-11-00190" ref-type="bibr">211</xref>,
 <xref rid="B212-viruses-11-00190" ref-type="bibr">212</xref>] sciIAVs have been evaluated as vaccine candidates.
</p>
